- Home
- IMTX vs EQBK Comparison
IMTX vs EQBK Comparison
Compare IMTX & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- EQBK
- Stock Information
- Founded
- IMTX N/A
- EQBK 2002
- Country
- IMTX Germany
- EQBK United States
- Employees
- IMTX N/A
- EQBK N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- EQBK Major Banks
- Sector
- IMTX Health Care
- EQBK Finance
- Exchange
- IMTX Nasdaq
- EQBK Nasdaq
- Market Cap
- IMTX 653.9M
- EQBK 773.5M
- IPO Year
- IMTX N/A
- EQBK 2015
- Fundamental
- Price
- IMTX $6.26
- EQBK $42.24
- Analyst Decision
- IMTX Strong Buy
- EQBK Buy
- Analyst Count
- IMTX 4
- EQBK 6
- Target Price
- IMTX $14.67
- EQBK $46.20
- AVG Volume (30 Days)
- IMTX 984.5K
- EQBK 92.1K
- Earning Date
- IMTX 08-13-2025
- EQBK 10-14-2025
- Dividend Yield
- IMTX N/A
- EQBK 1.42%
- EPS Growth
- IMTX N/A
- EQBK 532.31
- EPS
- IMTX N/A
- EQBK 4.01
- Revenue
- IMTX $152,823,253.00
- EQBK $227,628,000.00
- Revenue This Year
- IMTX N/A
- EQBK $19.34
- Revenue Next Year
- IMTX N/A
- EQBK $11.25
- P/E Ratio
- IMTX N/A
- EQBK $10.52
- Revenue Growth
- IMTX 83.61
- EQBK 48.83
- 52 Week Low
- IMTX $3.30
- EQBK $34.11
- 52 Week High
- IMTX $13.09
- EQBK $50.85
- Technical
- Relative Strength Index (RSI)
- IMTX 58.89
- EQBK 63.55
- Support Level
- IMTX $5.29
- EQBK $39.72
- Resistance Level
- IMTX $5.56
- EQBK $41.42
- Average True Range (ATR)
- IMTX 0.35
- EQBK 0.99
- MACD
- IMTX 0.04
- EQBK 0.28
- Stochastic Oscillator
- IMTX 85.03
- EQBK 74.06
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.